HK1149487A1 - Skin whitening agent and external preparation for the skin - Google Patents

Skin whitening agent and external preparation for the skin

Info

Publication number
HK1149487A1
HK1149487A1 HK11103715.5A HK11103715A HK1149487A1 HK 1149487 A1 HK1149487 A1 HK 1149487A1 HK 11103715 A HK11103715 A HK 11103715A HK 1149487 A1 HK1149487 A1 HK 1149487A1
Authority
HK
Hong Kong
Prior art keywords
skin
external preparation
whitening agent
skin whitening
agent
Prior art date
Application number
HK11103715.5A
Other languages
English (en)
Inventor
Hanyu Naoto
Saito Tomoko
Shibata Takako
Sato Kiyoshi
Ogino Kimihiro
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40952264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1149487(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of HK1149487A1 publication Critical patent/HK1149487A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11103715.5A 2008-02-08 2011-04-13 Skin whitening agent and external preparation for the skin HK1149487A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008029106 2008-02-08
JP2008199606 2008-08-01
PCT/JP2009/052077 WO2009099193A1 (ja) 2008-02-08 2009-02-06 美白剤及び皮膚外用剤

Publications (1)

Publication Number Publication Date
HK1149487A1 true HK1149487A1 (en) 2011-10-07

Family

ID=40952264

Family Applications (3)

Application Number Title Priority Date Filing Date
HK11103716.4A HK1149488A1 (en) 2008-02-08 2011-04-13 Skin whitening agent and external preparation for the skin
HK11103715.5A HK1149487A1 (en) 2008-02-08 2011-04-13 Skin whitening agent and external preparation for the skin
HK11104781.2A HK1150757A1 (en) 2008-02-08 2011-05-16 Skin whitening agent and external preparation for the skin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK11103716.4A HK1149488A1 (en) 2008-02-08 2011-04-13 Skin whitening agent and external preparation for the skin

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11104781.2A HK1150757A1 (en) 2008-02-08 2011-05-16 Skin whitening agent and external preparation for the skin

Country Status (12)

Country Link
US (6) US8563552B2 (xx)
EP (5) EP2250999B1 (xx)
JP (4) JP4665052B2 (xx)
KR (4) KR101037515B1 (xx)
CN (4) CN101965177A (xx)
AU (1) AU2009211564B2 (xx)
BR (1) BRPI0908143B1 (xx)
ES (4) ES2582227T3 (xx)
HK (3) HK1149488A1 (xx)
RU (1) RU2434634C1 (xx)
TW (4) TWI381856B (xx)
WO (4) WO2009099192A1 (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2250999B1 (en) * 2008-02-08 2016-04-13 Shiseido Company, Ltd. Skin whitening agent and external preparation for the skin
AR077999A1 (es) 2009-09-02 2011-10-05 Vifor Int Ag Antagonistas de pirimidin y triazin-hepcidina
DE102010002558A1 (de) 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
JP5164179B2 (ja) * 2009-12-28 2013-03-13 株式会社 資生堂 液状化粧料
JP4887454B2 (ja) * 2010-01-18 2012-02-29 株式会社 資生堂 ピリミジニルピラゾール化合物の製造方法
JP5693862B2 (ja) * 2010-02-24 2015-04-01 株式会社 資生堂 美白日焼け止め化粧料
EP2544542A4 (en) * 2010-03-10 2013-07-24 Galleon Pharmaceuticals Inc PAIN COMPOUNDS, COMPOSITIONS AND THEIR USE
DE102010012594A1 (de) * 2010-03-23 2011-09-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Thiazolderivaten
WO2011122840A2 (ko) * 2010-03-31 2011-10-06 (주)아모레퍼시픽 멜라닌 색소 생성 억제제 및 이를 함유하는 화장료 조성물
WO2012124436A1 (ja) * 2011-03-17 2012-09-20 株式会社 資生堂 皮膚化粧料
JP5162727B2 (ja) * 2011-04-12 2013-03-13 株式会社 資生堂 美白剤およびメラニン生成抑制剤
DE102011083259A1 (de) 2011-09-23 2013-03-28 Beiersdorf Ag Alkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Alkylamidothiazolen
DE102011083271A1 (de) * 2011-09-23 2013-03-28 Beiersdorf Ag Aromatische Amidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Aromatischen Amidothiazolen
DE102011083283A1 (de) 2011-09-23 2013-03-28 Beiersdorf Ag Heteroalkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Heteroalkylamidothiazolen
CN104411296A (zh) * 2012-05-16 2015-03-11 考希德芭以奧帕有限公司 含有鱼类眼球的粉碎物或提取物的化妆料、药学及食品组合物
DE102013204070A1 (de) 2013-03-11 2014-09-11 Beiersdorf Ag Verwendung kosmetisch oder dermatologisch unbedenklicher substituierter Michael-Akzeptoren zur Verhinderung, Verminderung oder Prophylaxe der Tyrosinaseaktivität der menschlichen Haut und/oder deren Aufhellung
DE102013204110A1 (de) 2013-03-11 2014-09-25 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einem oder mehreren Cyclodextrinen
DE102013204081A1 (de) 2013-03-11 2014-09-11 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch unbedenklichen Konservierungsmitteln
DE102013204088A1 (de) 2013-03-11 2014-09-11 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch relevanten Duftstoffen
DE102013204097A1 (de) * 2013-03-11 2014-10-30 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einer oder mehreren kosmetisch oder dermatologisch unbedenklichen UV-Filtersubstanzen
US9663529B2 (en) 2013-07-02 2017-05-30 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
JP6434968B2 (ja) 2013-07-02 2018-12-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｒｏｃｋ阻害剤としての三環式ピリド−カルボキサミド誘導体
CN103822976B (zh) * 2013-10-15 2015-05-27 辽宁省食品药品检验所 一种测定化妆品中4-甲氧基水杨酸钾的方法
WO2015079942A1 (ja) * 2013-11-29 2015-06-04 株式会社 Ｍｔｇ 水系スキンケア剤
PL3177612T3 (pl) 2014-08-04 2022-08-08 Nuevolution A/S Opcjonalnie skondensowane pochodne pirymidyny podstawione heterocyklilem, użyteczne w leczeniu chorób zapalnych, metabolicznych, onkologicznych i autoimmunologicznych
DE102014223570A1 (de) * 2014-11-19 2016-05-19 Beiersdorf Ag Zubereitungen mit einem Gehalt an Ascorbinsäure, Ubidecarenon und Phosphationen zur verbesserten Hautkonturierung bzw. gegen Cellulite
EP3259256B1 (en) * 2015-02-17 2022-03-09 Beijing Erai Therapeutics Co., Ltd. Compounds and methods for inducing browning of white adipose tissue
WO2016202935A1 (en) 2015-06-19 2016-12-22 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
US10774064B2 (en) 2016-06-02 2020-09-15 Cadent Therapeutics, Inc. Potassium channel modulators
US10646487B2 (en) 2016-07-14 2020-05-12 Showa Denko K.K. Melanin production inhibitor, whitening agent, fibroblast activator, collagen and/or elastin production promotor and wrinkle ameliorant
ES2906078T3 (es) 2017-01-23 2022-04-13 Cadent Therapeutics Inc Moduladores del canal de potasio
MX2020002347A (es) 2017-08-31 2020-10-28 Basf Se Uso de principios activos refrescantes fisiologicos y agentes que contienen dichos principios activos.
CN108929271B (zh) * 2018-06-29 2021-08-31 中国药科大学 酪氨酸酶抑制剂及其制备方法与用途
US11993586B2 (en) 2018-10-22 2024-05-28 Novartis Ag Crystalline forms of potassium channel modulators
CN109758379A (zh) * 2019-03-20 2019-05-17 广州纳丽生物科技有限公司 一种复方凝血酸组合物及其制备方法、产品
MX2022007265A (es) 2019-12-20 2022-09-09 Nuevolution As Compuestos activos frente a receptores nucleares.
WO2021198955A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
WO2021198956A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
CN112675076A (zh) * 2021-01-04 2021-04-20 上海新高姿化妆品有限公司 一种提亮肤色的化妆品组合物及其制备方法与应用
WO2023002873A1 (ja) * 2021-07-21 2023-01-26 株式会社資生堂 皮膚浸透用化粧料、及び皮膚浸透用化粧料の製造方法
DE102022209937A1 (de) 2022-09-21 2024-03-21 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und einem oder mehreren Biopolymeren
CN115991698B (zh) * 2022-11-03 2024-03-29 广东中科药物研究有限公司 一种杂环化合物及其制备方法与应用
WO2024135395A1 (ja) * 2022-12-22 2024-06-27 株式会社 資生堂 化粧料
WO2024142837A1 (ja) * 2022-12-26 2024-07-04 株式会社 資生堂 化粧料

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117029A (en) 1978-02-28 1979-09-11 Hokko Chem Ind Co Ltd Agricultural and horticultural microbicide
JPS6059883B2 (ja) 1978-05-08 1985-12-27 北興化学工業株式会社 農園芸用殺菌剤
JPS62404A (ja) 1985-06-25 1987-01-06 Takeda Chem Ind Ltd 農業用殺菌剤
DE3675197D1 (de) * 1985-12-03 1990-11-29 Sumitomo Chemical Co Pyridinylpyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende pflanzenkrankheiten-schutzmittel.
ZA868951B (en) 1985-12-07 1987-08-26 Shionogi & Company Limited Organophosphorus compounds having pesticidal activity
EP0264883A3 (en) * 1986-10-21 1990-04-04 Banyu Pharmaceutical Co., Ltd. Substituted pyridine derivatives
EP0278610A3 (en) * 1987-02-13 1990-03-14 Sumitomo Chemical Company, Limited Novel pyridinyl-s-triazine derivatives, method for production thereof and a fungicide containing them as the active ingredient
US5332627A (en) * 1990-10-30 1994-07-26 Sony Corporation Field emission type emitter and a method of manufacturing thereof
JP3033178B2 (ja) 1990-10-30 2000-04-17 ソニー株式会社 電界放出型エミッタ
JP2997071B2 (ja) 1991-01-11 2000-01-11 和彦 石井 痔疾治療剤
JP2680771B2 (ja) 1992-06-17 1997-11-19 大建工業株式会社 無機質下地板
JP2710088B2 (ja) * 1992-07-03 1998-02-10 宇部興産株式会社 ポリフッ化チアゾリン誘導体、その製法及び有害生物防除剤
JP3154834B2 (ja) * 1992-10-23 2001-04-09 第一製薬株式会社 チロシナーゼ阻害剤
JP3023178B2 (ja) 1994-11-29 2000-03-21 久光製薬株式会社 ２−アミノチアゾール誘導体およびその塩類からなる抗菌剤または殺菌剤
JPH08208620A (ja) 1995-02-03 1996-08-13 Takeda Chem Ind Ltd アミノピラゾール誘導体、その製造法および用途
JPH08231520A (ja) * 1995-02-28 1996-09-10 Showa Sangyo Co Ltd チロシナーゼ阻害剤
US5883254A (en) * 1996-11-08 1999-03-16 Hoffmann-La Roche Inc. Process for making pyrimidine derivatives
DE10008907A1 (de) * 2000-02-25 2001-08-30 Haarmann & Reimer Gmbh Topische kosmetische Mittel enthaltend benzokondensierte oder heterocyclisch kondensierte 2-Hydrazino-1,3-heteroazole
US20020016358A1 (en) * 2000-04-19 2002-02-07 Nof Corporation Cosmetic composition
DE10111050A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
US20040236110A1 (en) * 2001-09-26 2004-11-25 Ladouceur Gaetan H Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
US20040209924A1 (en) * 2001-09-26 2004-10-21 Barry Hart Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors
US20040198773A1 (en) * 2001-09-26 2004-10-07 Barry Hart Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors
US20040267017A1 (en) * 2001-09-26 2004-12-30 Bierer Donald E 3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors
WO2003027100A1 (en) 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors
EP1437348A1 (fr) * 2003-01-13 2004-07-14 L'oreal Dérivés de de la 6-méthyl-pyrimidine-2,4-diamine, procédé de synthèse, compositions les comprenant et utilisations comme agents neutralisants basiques
WO2004073594A2 (fr) * 2003-02-12 2004-09-02 L'oreal Utilisation d’un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
ES2314418T3 (es) 2003-05-02 2009-03-16 Elan Pharmaceuticals, Inc. Derivados de amidas del acido 4-bromo-5-(2-clorobenzoilamino)-1h-pirazol-3-carboxicilico y compuestos relacionados como antagonistas del receptor b1 de bradiquinina para el tratamiento de enfermedades inflamatorias.
AU2004257528A1 (en) * 2003-07-16 2005-01-27 Institute Of Medicinal Molecular Design. Inc. Medicament for treatment of dermal pigmentation.
US7223759B2 (en) * 2003-09-15 2007-05-29 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
US20090036475A1 (en) 2005-03-22 2009-02-05 Neurosearch A/S Pyrazolyl-Pyrimidines as Potassium Channel Modulating Agents and Their Medical Use
JP2008534472A (ja) 2005-03-22 2008-08-28 ノイロサーチ アクティーゼルスカブ カリウムチャンネル調節剤としてのピラゾリル−ピリミジン及びその医学的使用
FR2885128B1 (fr) * 2005-04-27 2007-07-06 Expanscience Laboratoires Sa Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant
BRPI0611798A2 (pt) * 2005-06-15 2009-01-13 Pfizer Ltd compostos de arilpirazàis substituÍdos, sua composiÇço farmacÊutica e uso
WO2006133876A1 (en) 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Use of pyrimidine derivatives for cosmetic purposes
KR100716891B1 (ko) * 2005-11-01 2007-05-09 (주)아모레퍼시픽 피리딘 티아졸 카복사마이드 유도체, 이의 제조방법 및이를 함유하는 피부 미백용 조성물
EP1978997A1 (en) 2005-12-22 2008-10-15 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
EP2250999B1 (en) * 2008-02-08 2016-04-13 Shiseido Company, Ltd. Skin whitening agent and external preparation for the skin

Also Published As

Publication number Publication date
KR20100120150A (ko) 2010-11-12
US20110003838A1 (en) 2011-01-06
TWI337876B (xx) 2011-03-01
KR101102640B1 (ko) 2012-01-04
EP2251000A4 (en) 2011-05-11
TW200938226A (en) 2009-09-16
WO2009099192A1 (ja) 2009-08-13
US8324234B2 (en) 2012-12-04
KR20100121617A (ko) 2010-11-18
CN101938988A (zh) 2011-01-05
HK1150757A1 (en) 2012-01-13
US20120134944A1 (en) 2012-05-31
CN101965176B (zh) 2012-06-20
US20110003817A1 (en) 2011-01-06
EP2250999A4 (en) 2011-05-11
US8426435B2 (en) 2013-04-23
WO2009099195A1 (ja) 2009-08-13
JPWO2009099195A1 (ja) 2011-05-26
JPWO2009099193A1 (ja) 2011-05-26
RU2434634C1 (ru) 2011-11-27
TWI381856B (zh) 2013-01-11
US8211412B2 (en) 2012-07-03
US20130045173A1 (en) 2013-02-21
EP2251000A1 (en) 2010-11-17
EP2250998A1 (en) 2010-11-17
TW200938228A (en) 2009-09-16
EP3067038A1 (en) 2016-09-14
HK1149488A1 (en) 2011-10-07
EP2250998B1 (en) 2016-04-13
JP4665052B2 (ja) 2011-04-06
TW200938229A (en) 2009-09-16
WO2009099194A1 (ja) 2009-08-13
CN101938988B (zh) 2013-06-19
KR101039220B1 (ko) 2011-06-03
CN101965177A (zh) 2011-02-02
US8563552B2 (en) 2013-10-22
BRPI0908143B1 (pt) 2016-12-20
TWI348920B (en) 2011-09-21
EP3067038B1 (en) 2017-10-11
ES2582227T3 (es) 2016-09-09
BRPI0908143A2 (pt) 2015-08-11
TW200938227A (en) 2009-09-16
EP2250998A4 (en) 2011-05-11
KR101047242B1 (ko) 2011-07-06
JPWO2009099194A1 (ja) 2011-05-26
JPWO2009099192A1 (ja) 2011-05-26
CN101938989B (zh) 2012-07-11
EP2250999A1 (en) 2010-11-17
EP2251000B1 (en) 2016-04-13
EP2250999B1 (en) 2016-04-13
KR101037515B1 (ko) 2011-05-26
WO2009099193A1 (ja) 2009-08-13
TWI353246B (en) 2011-12-01
ES2582228T3 (es) 2016-09-09
EP2251001A1 (en) 2010-11-17
ES2655305T3 (es) 2018-02-19
KR20100111293A (ko) 2010-10-14
JP4586108B2 (ja) 2010-11-24
EP2251001A4 (en) 2013-01-09
AU2009211564A1 (en) 2009-08-13
CN101938989A (zh) 2011-01-05
CN101965176A (zh) 2011-02-02
JP4592820B2 (ja) 2010-12-08
JP4613248B2 (ja) 2011-01-12
ES2582176T3 (es) 2016-09-09
US20100324096A1 (en) 2010-12-23
AU2009211564B2 (en) 2013-08-29
KR20100121618A (ko) 2010-11-18
US20100316584A1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
HK1150757A1 (en) Skin whitening agent and external preparation for the skin
EP2233154A4 (en) EXTERNAL SKIN PREPARATION
IL208458A0 (en) Compositions and methods for skin care
PL2278952T3 (pl) Środki do czyszczenia skóry i rąk
PL2059223T3 (pl) Kompozycja do pielęgnacji skóry
EP2254546A4 (en) TOPICAL COMPOSITIONS AND METHODS FOR LAUNDERING THE SKIN
EP2027849A4 (en) TOPICAL SKIN PREPARATION
HK1145965A1 (en) Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle
EP2127634A4 (en) COMPOSITION FOR SKIN OR HAIR
EP2168568A4 (en) SKIN COSMETICS
EP2450029A4 (en) EXTERNAL PREPARATION FOR THE SKIN
HK1156867A1 (en) External preparation for skin
GB0708938D0 (en) Skin care composition
GB2458228B (en) External preparation for skin
HK1137151A1 (en) Whitening agent
EP2062567A4 (en) CLEANING COMPOSITION FOR SKIN OR HAIR
HK1144441A1 (en) Alkylene oxide derivative and skin external preparation containing the same
HK1146580A1 (en) Skin cosmetic
GB0903158D0 (en) Cosmetic or pharmaceutical preparation for the skin
GB0719202D0 (en) Compositions and methods for the skin and hair
HK1126959A1 (en) Skin-whitening agent for external application to the skin, and method for whitening the skin
EP2403502A4 (en) MEDICAL-COSMETIC LIPOATROPHY
EP2363132A4 (en) USE OF SOPHORICOSIDE IN DRUG MANUFACTURE
EP2042153A4 (en) skin cosmetic
EP2156820A4 (en) SKIN WHITENING AGENT

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210208